A demyelinating disease affecting the brain and spinal cord
A sweeping Timms review finds the Personal Independence Payment not fit for purpose and not serving disabled people or taxpayers well. Interim proposals call for bold reform while spending on the benefit continues to rise, driven largely by mental-health related claims.
The NHS has approved fampridine (Fampyra) to help some people with multiple sclerosis walk more easily. Up to 5,000 in England may benefit each year after trials showed improved walking speed and duration. Patients will undergo a 2–4 week trial, with continued use for those showing clear benefit; private costs previously limited access.